H04.142 Primary lacrimal gland atrophy, left lacrimal gland

Name of the Condition

• Primary Lacrimal Gland Atrophy, Left Lacrimal Gland (ICD-10 code: H04.142)

Summary

Primary lacrimal gland atrophy, left lacrimal gland, is a condition involving the progressive degeneration or shrinkage of the left lacrimal gland, which is responsible for tear production. This can lead to reduced tear output, resulting in dry eye symptoms or ocular discomfort. The term "primary" indicates the atrophy occurs without an identifiable underlying cause, distinguishing it from secondary atrophy linked to other diseases or trauma.

Causes

The exact cause of primary lacrimal gland atrophy is not fully understood. It is thought to involve age-related changes, autoimmune processes, or degenerative mechanisms affecting the gland tissue. Unlike secondary atrophy, no specific infection, trauma, or systemic disease is identified as the trigger in primary cases.

Risk Factors

Risk factors may include advanced age, as glandular tissue naturally declines over time. Genetic predisposition or a history of autoimmune conditions could also increase susceptibility, though specific associations are not well established for primary cases.

Symptoms

Symptoms typically include persistent dryness, burning, or grittiness in the left eye. Patients may experience reduced tear production, leading to discomfort, redness, or a sensation of foreign bodies. Vision may be temporarily blurred due to insufficient lubrication.

Diagnosis

Diagnosis involves a clinical evaluation, including a review of symptoms and eye examination. Tests such as Schirmer’s test (to measure tear production) or imaging studies (e.g., MRI) may be used to assess gland structure. Exclusion of secondary causes (e.g., trauma, infection, or systemic disease) is essential to confirm a primary diagnosis.

Treatment Options

Treatment focuses on managing symptoms, such as using artificial tears or lubricating eye drops to alleviate dryness. In some cases, anti-inflammatory medications or immunosuppressants may be considered if an autoimmune component is suspected. Regular monitoring by an eye care professional is recommended.

Prognosis and Follow-Up

Prognosis varies depending on the severity of gland atrophy. While the condition is typically chronic, symptom management can improve quality of life. Follow-up appointments may be necessary to monitor tear production and adjust treatment as needed.

Complications

Complications may include chronic dry eye, corneal damage from insufficient lubrication, or increased risk of eye infections due to reduced tear protection. Severe cases could lead to vision impairment if left untreated.

Lifestyle & Prevention

Lifestyle measures include avoiding environmental irritants (e.g., smoke or dry air) and using humidifiers to maintain eye moisture. Protective eyewear in windy or dry conditions may help reduce symptoms. No specific preventive measures exist for primary atrophy.

When to Seek Professional Help

Seek medical attention if dry eye symptoms persist, worsen, or are accompanied by pain, redness, or vision changes. Early evaluation can help rule out other conditions and initiate appropriate management.

Tips for Medical Coders

Document the laterality (left lacrimal gland) clearly in the medical record to support code assignment. Ensure the diagnosis is confirmed as "primary" (without secondary causes) to align with the code’s specificity. Include details of clinical findings or tests that differentiate this condition from other lacrimal gland disorders.